A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Novaferon in Patients with Advanced Cancer.

Trial Profile

A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Novaferon in Patients with Advanced Cancer.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Novaferon (Primary)
  • Indications Cancer
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date (31 Dec 2009) added as reported by Chinese Clinical Trial Register.
    • 20 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top